P. Muñoz, J. Palomo, J. Yáñez, E. Bouza

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

J. Feyjoo Casero, K.L. Enguez, T.W. Jorgensen, F.J.P. Rodríguez

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN method Kleinkauf N. , Rodloff A.C. Clinical Microbiology.

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome J. Guinea, M. Torres-Narbona, P.

Clinical microbiological case: poor radiologic evolution of pulmonary tuberculosis in a heart transplant patient F. Gavilán, J. Torre-Cisneros, M.A.

Recurrent catheter-related Rhodotorula rubra infection

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients M. Giannella, M. Alonso,

Herpes zoster in non-hospitalized children

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

B. Maraha, H. Bonten, H. van Hooff, H. Fiolet, A. G. Buiting, E. E

J. Feyjoo Casero, K.L. Enguez, T.W. Jorgensen, F.J.P. Rodríguez

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Pyogenic hepatic abscess: clues for diagnosis in the emergency room

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Environmental surveillance and other control measures in the prevention of nosocomial fungal infections P. Muñoz, A. Burillo, E. Bouza Clinical Microbiology.

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

E. Bouza, P. Muñoz, R. Alonso Clinical Microbiology and Infection

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Laboratory diagnosis and biosafety issues of biological warfare agents

Aerococcus: an increasingly acknowledged human pathogen

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Mathematical modeling of Clostridium difficile infection

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease Inge O. Baas, G. Johan A. Offerhaus, Ralph.

G.R. Davies Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Clinical microbiological case: poor radiologic evolution of pulmonary tuberculosis in a heart transplant patient F. Gavilán, J. Torre-Cisneros, M.A.

Brucella detection in blood: comparison of the BacT/Alert standard aerobic bottle, BacT/Alert FAN aerobic bottle and BacT/Alert enhanced FAN aerobic bottle.

Pathogenesis of catheter-related infections: lessons for new designs

R. Colebunders, P. Michielsen Clinical Microbiology and Infection

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Training in infectious diseases and tropical medicine in Britain

J. R. Blanco, C. Gutierrez, M. Zabalza, J. Salcedo, I. Erdozain, J. A

Clinical infection services—the Leiden experience

Training in infectious diseases—looking to the future

Clinical Microbiology and Infection

E. Bouza, P. Muñoz Clinical Microbiology and Infection

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Update on invasive aspergillosis: clinical and diagnostic aspects

Carratalà J. Clinical Microbiology and Infection

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

J.L. Balcázar Clinical Microbiology and Infection

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

Typing of Clostridium difficile

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

Detection of human cytomegalovirus (HCMV) pp67-mRIMA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients

The future of diagnostic bacteriology

Presentation transcript:

Clinical microbiological case: a heart transplant recipient with diarrhea and abdominal pain P. Muñoz, J. Palomo, J. Yáñez, E. Bouza Clinical Microbiology and Infection Volume 7, Issue 8, Pages 451-452 (August 2001) DOI: 10.1046/j.1198-743x.2001.00315.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Abdominal radiograph showing dilated colon and wall edema. Clinical Microbiology and Infection 2001 7, 451-452DOI: (10.1046/j.1198-743x.2001.00315.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Colonies in a plate of cycloserine, cefoxitin, and fructose agar in an egg-yolk agar base. Clinical Microbiology and Infection 2001 7, 451-452DOI: (10.1046/j.1198-743x.2001.00315.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions